Xspray Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Xspray Pharma has a total shareholder equity of SEK585.6M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK667.7M and SEK82.1M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 74.76m |
| Equity | SEK 585.59m |
| Total liabilities | SEK 82.10m |
| Total assets | SEK 667.70m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6XP's short term assets (SEK101.5M) exceed its short term liabilities (SEK53.5M).
Long Term Liabilities: 6XP's short term assets (SEK101.5M) exceed its long term liabilities (SEK28.6M).
Debt to Equity History and Analysis
Debt Level: 6XP is debt free.
Reducing Debt: 6XP has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6XP has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 6XP is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.